Search Results - "Ellison, George W."

Hematopoietic stem cell transplantation for multiple sclerosis by Burt, Richard K, Cohen, Bruce, Rose, John, Petersen, Finn, Oyama, Yu, Stefoski, Dusan, Katsamakis, George, Carrier, Ewa, Kozak, Tomas, Muraro, Paolo A, Martin, Roland, Hintzen, Roger, Slavin, Shimon, Karussis, Dimitrios, Haggiag, Shalom, Voltarelli, Julio C, Ellison, George W, Jovanovic, Borko, Popat, Uday, McGuirk, Joseph, Statkute, Laisvyde, Verda, Larissa, Haas, Judith, Arnold, Renate

Get more information

Development of a multiple sclerosis functional composite as a clinical trial outcome measure by Cutter, Gary R., Baier, Monika L., Rudick, Richard A., Cookfair, Diane L., Fischer, Jill S., Petkau, John, Syndulko, Karl, Weinshenker, Brian G., Antel, Jack P., Confavreux, Christian, Ellison, George W., Lublin, Fred, Miller, Aaron E., Rao, Stephen M., Reingold, Stephen, Thompson, Alan, Willoughby, Ernest

“…The primary clinical outcome measure for evaluating multiple sclerosis in clinical trials has been Kurtzke's expanded disability status scale (EDSS). New…”
Get full text

Criteria for the clinical diagnosis of multiple sclerosis by Rose, A S, Ellison, G W, Myers, L W, Tourtellotte, W W

Get full text

Progressive multifocal leukoencephalopathy (PML). I. Investigation of the immunologic status of a patient with lymphosarcoma and PML by Ellison, G W

Get more information

A comparison of health-related quality of life in patients with epilepsy, diabetes and multiple sclerosis by Hermann, Bruce P., Vickrey, Barbara, Hays, Ron D., Cramer, Joyce, Devinsky, Orrin, Meador, Kimford, Perrine, Kenneth, Myers, Lawrence W., Ellison, George W.

“…The purpose of this investigation was to compare self-reported health-related quality of life (HRQOL) in epilepsy compared to another neurological condition or…”
Get full text

Comparison of a generic to disease-targeted health-related quality-of-life measures for multiple sclerosis by Vickrey, Barbara G., Hays, Ron D., Genovese, Barbara J., Myers, Lawrence W., Ellison, George W.

“…Evaluation of the relative contributions of generic and disease-targeted measures to assessing health-related quality of life (HRQOL) for chronic conditions is…”
Get full text

Quantitative multiple sclerosis plaque assessment with magnetic resonance imaging. Its correlation with clinical parameters, evoked potentials, and intra-blood-brain barrier IgG synthesis by Baumhefner, R W, Tourtellotte, W W, Syndulko, K, Waluch, V, Ellison, G W, Meyers, L W, Cohen, S N, Osborne, M, Shapshak, P

“…Magnetic resonance imaging (MRI) of the cerebrum, cerebellum, brain stem, and upper cervical cord was performed in 62 individuals with clinically definite…”
Get more information

A working protocol to be used as a guideline for trials in multiple sclerosis by Weiner, H L, Ellison, G W

Get more information

Epstein-Barr virus antibodies in multiple sclerosis by Sumaya, C V, Myers, L W, Ellison, G W

“…Serum antibody titers to Epstein-Barr virus (EBV), an agent that persists in a latent form after the initial infection, were determined in 157 patients with…”
Get more information

Evoked potentials during multiple sclerosis therapeutic trials by Nuwer, M R, Ellison, G W, Myers, L W

Get more information

Failure to detect human T-cell leukemia virus-related sequences in multiple sclerosis blood by Chen, I S, Haislip, A M, Myers, L W, Ellison, G W, Merrill, J E

“…We tested 11 patients with multiple sclerosis for the presence of human T-cell leukemia virus type I (HTLV-I)- or type II (HTLV-II)-related sequences. DNA from…”
Get more information

Correlation of clinical and immunologic states in multiple sclerosis by Mickey, M R, Ellison, G W, Fahey, J L, Moody, D J, Myers, L W

“…Cyclophosphamide was administered to 14 patients with chronic progressive multiple sclerosis on an intermittent escalating dosage schedule adjusted to maintain…”
Get more information

Cyclophosphamide 'pulses' in chronic progressive multiple sclerosis. A preliminary clinical trial by Myers, L W, Fahey, J L, Moody, D J, Mickey, M R, Frane, M V, Ellison, G W

“…To our knowledge, this is the first clinical trial in multiple sclerosis (MS) demonstrating the feasibility of directing immunomodulating therapy by monitoring…”
Get more information

Antisense blockade of inducible nitric oxide synthase in glial cells derived from adult SJL mice by Ding, Minzhen, Zhang, Ming, Wong, Joyce L., Voskuhl, Rhonda R., Ellison, George W.

“…Increasing evidence suggests a correlation between cytokine-induced nitric oxide synthase (iNOS) and demyelination in Multiple sclerosis (MS). Inhibition of…”
Get full text

Interaction by Ellison, George W., Silberberg, Donald H.

Get full text

Opening remarks by Myers, Lawrence W., Ellison, George W.

Get full text

Closing remarks by Myers, Lawrence W., Ellison, George W.

Get full text

Evoked potentials predict the clinical changes in a multiple sclerosis drug study by NUWER, M. R, PACKWOOD, J. W, MYERS, L. W, ELLISON, G. W

“…Visual, brainstem auditory, and median nerve somatosensory evoked potential (EP) tests were performed annually during a 3-year, double-blind,…”
Get full text

In vitro study of mediators of inflammation in multiple sclerosis by MERRILL, J. E, STROM, S. R, ELLISON, G. W, MYERS, L. W

“…Prostaglandin E levels have previously been demonstrated to be elevated in multiple sclerosis (MS). We have further investigated other products of activated…”
Get full text

Increased prevalence and titer of Epstein-Barr virus antibodies in patients with multiple sclerosis by Sumaya, C V, Myers, L W, Ellison, G W, Ench, Y

“…The prevalence and titer of serum antibodies to several Epstein-Barr virus (EBV) antigens were compared among patients with multiple sclerosis, healthy…”
Get more information